Element Biosciences Stock

elementbiosciences.comHealthcareFounded: 2017Funding to Date: $407.92MM

Element Biosciences developing disruptive DNA sequencing technology for research and diagnostic markets to empower customers with affordable high-quality data and an improved user experience.

Register for Details

For more details on financing and valuation for Element Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Element Biosciences.

Register Today

Other companies like Element Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

The San Diego-based startup plans to address the US research market with its Aviti short-read sequencing platform and Avidity sequencing chemistry.
The collaborations will make the Aviti platform compatible with NGS products from Roche, Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics.